Internal Server Error

Ossio - About the company

Ossio is a series C company based in Caesarea (Israel), founded in 2014 by Orahn Preiss Bloom. It operates as a Bone regeneration biocomposite. Ossio has raised $89M in funding from investors like MVM, Questa Capital and OCV Partners. The company has 135 active competitors, including 41 funded and 26 that have exited. Its top competitors include companies like RevBio, Theradaptive and MiMedx Group.

Company Details

Ossio focuses on orthopedic fixation using bone regeneration technology. The company has developed OSSIOfiber, a biocomposite material platform that contains reinforcing synthetic bone fibers and bioabsorbable polymer resin. The fiber provides mechanical strength and the resin provides binding property and promotes bone growth.
Website
ossio.io
Social
X
Email ID
*****@ossio.io
Registered Address
25 ROBERT PITT DRIVE,SUITE 204,MONSEY,NY,10952
Key Metrics
Founded Year
2014
Location
Caesarea, Israel
Stage
Series C
Total Funding
$89M in 5 rounds
Investors
Ranked
Employee Count
168 as on Aug 31, 2026
Similar Companies
Sign up to download Ossio's company profile

Ossio's funding and investors

Ossio has raised a total funding of $89M over 5 rounds. Its first funding round was on Jan 03, 2018. Its latest funding round was a Conventional Debt round on Feb 12, 2026 for $*****. 2 investors participated in its latest round. Ossio has 9 institutional investors.

Here is the list of recent funding rounds of Ossio:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 12, 2026
5136901
Conventional Debt
9396708
9699446
6168566
6356591
Dec 02, 2024
3017699
Series C
4378618
5550473
1460059
Oct 17, 2022
3911578
Series C
9485602
7530483
7567714
lockAccess funding benchmarks and valuations. Sign up today!

Ossio's founders and board of directors

Founder? Claim Profile
The founders of Ossio is Orahn Preiss Bloom. Brian Verrier is the CEO of Ossio.
Here are the details of Ossio's key team members:

Ossio's employee count trend

Ossio has 168 employees as of Aug 26. Here is Ossio's employee count trend over the years:
Employee count trend for Ossio
lockUncover Ossio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Ossio's Competitors and alternates

Top competitors of Ossio include RevBio, Theradaptive and MiMedx Group. Here is the list of Top 10 competitors of Ossio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Ossio
Ossio
2014, Caesarea (Israel), Series C
Bone regeneration biocomposite
$89M
64/100
2nd
Logo for RevBio
RevBio
2014, Lowell (United States), Series B
Developer of synthetic adhesive used for bone/dental repair
$27.5M
63/100
3rd
Logo for Theradaptive
Theradaptive
2004, Boston (United States), Series B
Developer of protein engineering technology creating targeted therapeutics for tissue repair
$50M
61/100
4th
Logo for MiMedx Group
MiMedx Group
1985, Marietta (United States), Public
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
-
61/100
5th
Logo for Cerapedics
Cerapedics
1996, Westminster (United States), Series D
Developer of Osteobiologic products
$88.5M
58/100
6th
Logo for Serigen
Serigen
2015, Pune (India), Seed
Develops silk protein-based biomedical products for tissue regeneration and healing
$3.63M
53/100
7th
Logo for Tissue Regenix
Tissue Regenix
2006, Swillington (United Kingdom), Public
Developer of regenerative medical devices by using cell technology
-
53/100
8th
Logo for Epibone
Epibone
2013, Brooklyn (United States), Series B
Developer of patient‑specific bone and cartilage grafts
$48.6M
51/100
9th
Logo for Royal Biologics
Royal Biologics
2015, Jersey City (United States), Series A
Innovating orthobiologics and wound care solutions for enhanced healing
$19.6M
47/100
10th
Logo for Aziyo Biologics
Aziyo Biologics
2015, Silver Spring (United States), Public
Developer of regenerative medicine products for various applications
$49.6M
47/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Ossio's competitors? Click here to see the top ones

Ossio's Investments and acquisitions

Ossio has made no investments or acquisitions yet.

Reports related to Ossio

Here is the latest report on Ossio's sector:

News related to Ossio

lockFilter this list
Media has covered Ossio for a total of 4 events in the last 1 year, 3 of them have been about company updates.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Ossio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford